Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk
Open Access
- 27 October 2011
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 105 (12) , 1934-1939
Abstract
Somatic mutations in phosphoinositide-3-kinase catalytic subunit alpha (PIK3CA) are frequent in breast tumours and have been associated with oestrogen receptor (ER) expression, human epidermal growth factor receptor-2 overexpression, lymph node metastasis and poor survival. The goal of this study was to evaluate the association between inherited variation in this oncogene and risk of breast cancer. A single-nucleotide polymorphism from the PIK3CA locus that was associated with breast cancer in a study of Caucasian breast cancer cases and controls from the Mayo Clinic (MCBCS) was genotyped in 5436 cases and 5280 controls from the Cancer Genetic Markers of Susceptibility (CGEMS) study and in 30 949 cases and 29 788 controls from the Breast Cancer Association Consortium (BCAC). Rs1607237 was significantly associated with a decreased risk of breast cancer in MCBCS, CGEMS and all studies of white Europeans combined (odds ratio (OR)=0.97, 95% confidence interval (CI) 0.95–0.99, P=4.6 × 10−3), but did not reach significance in the BCAC replication study alone (OR=0.98, 95% CI 0.96–1.01, P=0.139). Common germline variation in PIK3CA does not have a strong influence on the risk of breast cancerKeywords
This publication has 23 references indexed in Scilit:
- Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium StudiesJNCI: Journal of the National Cancer Institute, 2010
- PIK3CAmutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor–positive breast cancerProceedings of the National Academy of Sciences, 2010
- PIK3CA expression in invasive breast cancer: a biomarker of poor prognosisBreast Cancer Research and Treatment, 2009
- PIK3CA Mutation Associates with Improved Outcome in Breast CancerClinical Cancer Research, 2009
- A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)Nature Genetics, 2009
- An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast CancerCancer Research, 2008
- Association of Genetic Variation in Genes Implicated in the β-Catenin Destruction Complex with Risk of Breast CancerCancer Epidemiology, Biomarkers & Prevention, 2008
- PI3K/Akt signalling pathway and cancerCancer Treatment Reviews, 2004
- The Phosphoinositide 3-Kinase PathwayScience, 2002
- PIK3CA as an oncogene in cervical cancerOncogene, 2000